In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 207.74 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.29 trading at $0.08 or 38.23% at ring of the bell on the day assigns it a market valuation of $2.62M. That closing price of QNRX’s stock is at a discount of -441.38% from its 52-week high price of $1.57 and is indicating a premium of 27.59% from its 52-week low price of $0.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 21.21 million shares which gives us an average trading volume of 5.38 million if we extend that period to 3-months.

For Quoin Pharmaceuticals Ltd ADR (QNRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information

Upright in the green during last session for gaining 38.23%, in the last five days QNRX remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $0.29 price level, adding 30.95% to its value on the day. Quoin Pharmaceuticals Ltd ADR’s shares saw a change of -55.05% in year-to-date performance and have moved -0.85% in past 5-day. Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) showed a performance of -0.85% in past 30-days. Number of shares sold short was 0.87 million shares which calculate 0.1 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -143.98% during past 5 years.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders

Insiders are in possession of 7.08% of company’s total shares while institution are holding 7.51 percent of that, with stock having share float percentage of 8.08%. Investors also watch the number of corporate investors in a company very closely, which is 7.51% institutions for Quoin Pharmaceuticals Ltd ADR that are currently holding shares of the company.